peter foley

neurology consultant, nhs lothian
hon clinical sen lecturer, uni of edinburgh

disease biology, symptoms
🧠 🔬🤓 ||🚴 🌍 🌱

#MS #HuntingtonsDisease #Neurology

[Neurosciences, RIE @DCNNeuro]

Our rapidly expanding MS team is recruiting for Specialist Nurses - get in touch if you’re interested in joining the team @AnneRowlClinic @hesterniven1 https://t.co/BIPakldqTq

[John Burn-Murdoch @jburnmurdoch]

NEW: we need to talk about NHS staff retention.

At a time when Britain’s healthcare system is acutely short of workers, *1 in 7* UK-trained doctors are practising overseas. No other developed country is like this, which immediately tells you there’s a problem.

Let’s dig deeper:

[UCL Innovative Clinical Trials Unit @innovativectu]

Great to see @DrRanj on @BBCMorningLive bringing attention to the OCTOPUS trial for #MSAwarenessWeek.

OCTOPUS is a multi-arm multi-stage trial, which allows our researchers to test treatments for progressive #MS much faster than traditional #ClinicalTrials.

[Scottish Huntington's Association @ScottishHD]

Good luck to SHA supporters taking on the 23 mile Glasgow #Kiltwalk this weekend. They include staff from Florence House care home, Govan, who have been inspired by Huntington's families and our work to ensure they have specialist support. Thank you!
#Glasgowkiltwalk #TeamSHA

[peter foley @peterfoley10]

@EuroHuntington @PrileniaTx ... the Prilenia trial did not meet its primary endpoint, which was an improvement in functional capacity as measured by the Unified Huntington Disease Rating Scale-Total Functional Capacity, and also did not meet a key secondary endpoint,

[MSJ @MSJ_Research]

1 out of 2 people with #MultipleSclerosis have fatigue worsening over 5 years, which is then associated with lower income, increasing disability, injectable DMTs, and increasing depression.

#NACTRIMS Registry study from @UTSWNews 🔽
https://t.co/dmx6VO7WGl

[Dr. Brandon Beaber @Brandon_Beaber]

A summary of studies on remyelinating agents for multiple sclerosis is somewhat unimpressive with most drugs failing. Clemastine is likely the most promising, but will it work in [actively recruiting] phase III trials? https://t.co/6jWJbUQPld

[goodmoves.org @goodmovesjobs]

Huntington’s Disease Specialist @ScottishHD Are you looking for a role in which you will contribute to improving the lives of families in your community and beyond? https://t.co/gehnHzk27X £31,615 – £34,976 FT Lothian Home based at present #CharityJob

[David Gillespie @DCGillespie_PhD]

Stroke Cochrane Corner summary of our recent perceptual disorders review, just published...

Interventions for Perceptual Disorders in Stroke: A Systematic Review https://t.co/0s6ZOkPs31

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

There’s still time to apply for the Rowling Clinical Fellow post - closing Mon 17th April.
In this short video, Hatice tells you more about the Rowling Clinical Fellows position. #Research_MS #Research_MND
For full video & application link visit: https://t.co/sSTXbUWDRl

[MS Society UK @mssocietyuk]

Octopus, the world's first multi-arm, multi-stage trial for progressive MS, has started recruitment! #StopMS

But what is Octopus? And how does it work?

Trial lead Professor Jeremy Chataway explains Octopus and how it will test treatments.📽️⬇️

Read more: https://t.co/tbH3wTjNun

[NHS Lothian @NHS_Lothian]

People eligible for the spring booster will be contacted about their appointment.

Due to maintenance on the national booking portal, not all clinics may be visible over the coming days.

If you need to reschedule, but can't find a suitable appointment, please keep checking.

1/2

[Anne Rowling Regenerative Neurology Clinic @AnneRowlClinic]

(1 of 5) 📢We're recruiting!
Positions for Aug 2023 #EdinburghUni
Deadline Apr 17th.

1) Clinical Fellow in Regenerative Neurology - 1yr
2) Clinical PhD Scholar - 3yr with #PhD registration
3) Graduate Research Practitioner - 1yr #graduatejob

More about each in 🧵below!

[peter foley @peterfoley10]

@JNewton_MND @AnneRowlClinic Happy birthday Liz! 🎈 🎈 🎂

[Nils Winter @NilsRWinter]

Biomarkers of Major Depression? Well, not really...and not for lack of trying...

Happy to share our latest preprint on the subject ->
https://t.co/BIqal0Ptl4

We realize, of course, that predicting diagnosis is neither the most useful nor the most interesting goal. However,...

[peter foley @peterfoley10]

'@'ing a few people who might be interested in this and related work. 👍 And 🙏 if not! 😁

@KRayChaudhuri1 @imscogs @1Squito @OxfordWIN @markus_ploner
@lance_mccracken @DrZoffness @FlippinPain

[peter foley @peterfoley10]

🎈 New paper @AnneRowlClinic #FUTUREMS group🎈

Could there be a connection between #pain, #cognition, in #multiplesclerosis? Sides of the same coin? 🐥 /🥚? Opportunity for intervention?

https://t.co/CZ6es04tx4

🎺 Fraser brown (not on twitter)

[peter foley @peterfoley10]

Seven clinical studies identified worse #pain~worse #cognition on cognitive testing.

Two found the opposite, we discuss possible methodological issues.

Gaps in knowledge.

[Neurology Today @NeurologyToday]

Via @ACTRIMS: ​Imaging of people with relapsing remitting #MultipleSclerosis revealed no benefit from high-dose #VitaminD compared with a low-dose regimen, according to a phase 3 randomized, double-blind trial: https://t.co/KazGuklyJH

#neurotwitter #MS #ACTRIMSForum @AANMember